| surveillance of htlv infection in england and wales: 1986-1992. | the epidemiology of infection with human t cell leukaemia/lymphoma virus (htlv) types i and ii in england and wales between 1986 and 1992 has been studied. two sources of data have been reviewed: reports of cases of infection received by the phls communicable disease surveillance centre, and information about people infected with htlv-i and ii provided on laboratory request forms sent to the virus reference division of the phls central public health laboratory. most patients were of caribbean or ... | 1994 | 7519514 |
| in the shadow of hiv-htlv infection in england and wales, 1987-2001. | like human immunodeficiency virus (hiv), human t-cell leukaemia/ lymphoma viruses (htlv) i and ii are persistent retroviral infections. once infected, the lifetime risk of developing the htlv-associated diseases, malignant or inflammatory, is low (approximately 5%). for those affected, however, these diseases are debilitating, with few treatment options and a poor prognosis. surveillance of htlv infections by the communicable disease surveillance centre (cdsc) has been ongoing since serological ... | 2004 | 15481213 |
| htlv infection in england and wales in 2002--results from an enhanced national surveillance system. | human t-cell lymphotropic virus (htlv) is a retrovirus transmitted through breastfeeding, sexual contact, blood transfusion and injecting drug use. htlv is endemic in the caribbean and parts of africa, japan and south america, with isolated foci in other areas. infection is life-long. less than 5% of those infected progress to one of the htlv-related diseases, but these are debilitating and often fatal. laboratory reports of new htlv diagnoses are followed up through clinicians to establish info ... | 2004 | 15481214 |